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After six months: VAS, uCTX-I and uCTX-II. After one year: VAS, uCTX-I,
uCTX-II and radiographs.
Results: After 6 months and 1 year of treatment VAS, uCTX-I and uCTX-
II mean values were signiﬁcantly lower than the baseline. 57 were treated
with GCC and 47 with GC. The group that received GCC showed a similar
VAS mean value after 6 months and 1 year when compared with the group
treated with GC. uCTX-I and uCTX-II mean level was lower in the group
treated with GCC (p< 0.05). Radiological score (Kellgren and Lawrence
summarized score for hands) after 1 year showed a reduced progression
compared to the baseline in the hand osteoarthritis group, especially
after GCC treatment (p< 0.05). Finally, uCTX-I has better correlation with
radiological score and with GC in the EOA subgroup (Pearson index:
R=0.44).
Conclusions: (a) uCTX-I and uCTX-II proved to be useful biomarkers
in OAmonitoring; (b) uCTX-I is better correlated with hand EOA and
could represent a potential further marker to asses the evolution of EOA
bone damage; (c) glucosamine and chondroitinsulphate slow down OA
progression; (d) ﬁnally COLLII could represent a further protective factor
in OA cartilage.
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Purpose: To determine the proﬁle of Coll2−1, Coll2−1NO2 and myeloper-
oxydase (MPO) serum concentrations in experimental knee OA induced
in the dog by transection of the anterior cruciate ligament
Methods: Surgical transection of the ACL of the right knee was performed
on 16 adult crossbred dogs. The dogs were sacriﬁced 8 weeks after
the surgical procedure. Coll2−1, Coll2−1NO2 and MPO were measured
by speciﬁc immunoassays in 16 dogs at baseline and every 2 weeks
during the 8 weeks. The results were expressed as median (range). The
Friedman test estimated the variation for each biomarker every 2 weeks
during the 8 weeks.
Results: Immunostainings with D3 and D37, the antiserum recognizing
Coll2−1 and Coll2−1NO2, respectively, labelled extracellular matrix in the
superﬁcial layer of ﬁbrillated cartilage. After the transection of the ACL,
the concentration of 3 biomarkers increased signiﬁcantly (Friedman test:
Coll2−1, Coll2−1NO2 and MPO: p< 0.001). The concentrations of Coll2−1
and MPO were signiﬁcantly increased at week 2 compared to baseline
[Coll2−1 baseline: 281.57 (131.02–384.67) nM vs Coll2−1 week 2: 345.52
(181.15–589.25) nM (p< 0.01) and MPO baseline: 5.16 (<0.4−14.7) ng/ml
vs MPO week 2: 14.54 (3.28−31.50) ng/ml (p< 0.001)] and remained sta-
ble until week 8 [Coll2−1 week 8: 318.89 (117.95–492.28) nM and MPO
week 8: 11.55 (2.87−42.94) ng/ml]. The Coll2−1NO2 concentration in-
creased signiﬁcantly at weeks 6 and 8 compared to baseline [Coll2−1NO2
baseline: 0.54 (0.29−1.48) nM vs Coll2−1NO2 week 6: 0.64 (0.40−1.9)
nM (p< 0.001) vs week 8: 0.61 (0.37−1.79) nM]. The global macroscopic
score correlated positively with the 8-week changes of Coll2−1 (r = 0.57,
p = 0.02). No similar correlations were found for Coll2−1NO2 and MPO.
Finally, there was a positive correlation between the 4-week changes of
Coll2−1 and Coll2−1NO2 and the microscopic score of cartilage lesion
severity (condyles; Coll2−1: r = 0.56, p = 0.025 and Coll2−1NO2: r = 0.52,
p = 0.049). No similar correlations were found for MPO.
Conclusions: These ﬁndings suggest that Coll2−1 is a relevant marker
for the detection of early structural changes in OA dogs. Interestingly,
MPO and Coll2−1NO2 are increased in OA dogs indicating that an
oxidative stress occurs in this OA model.
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Purpose: Aggrecan proteolysis is an early key event in arthritis releasing
fragments into the synovial ﬂuid (SF). In understanding the mechanisms
of cartilage degradation and identifying OA biomarkers detailed aggrecan
fragment patterns from human joint diseases and disease stages are
helpful. This can be obtained by Western blot analysis. We have analyzed
how different preparation methods for SF aggrecan fragments affect
the puriﬁcation levels, sulfated glycosaminoglycan (sGAG) yields and
Western blot immuno patterns.
Methods: Aggrecan fragments were puriﬁed from a human SF-pool
(n> 100, from OA and knee injuries) by: (1) Dissociative and associa-
tive CsCl density gradient centrifugation collecting D1 and A1 fractions;
(2) Boiling SF and collecting supernatant after centrifugation; (3) Blue
SepharoseTM chromatography at pH 7 collecting the non binding ﬂow-
through; (4) Anion chromatography (Mono-QTM or Q-SepharoseTM) at
pH 5 collecting the 2M or 3M NaCl batch eluates. Puriﬁed aggrecan sam-
ples were deglycosylated, separated by SDS-PAGE, transferred to PVDF
membranes and probed with antibodies against aggrecanase generated
neo-epitopes (ARGS, TEGE, SELE, KEEE and LGQR) or against G1-
and G3-domains. sGAG was analyzed by Alcian Blue precipitation, total
protein by BCA method.
Table 1. Puriﬁcation of aggrecan fragments from a human SF-pool
Puriﬁcation method Puriﬁed sample sGAG recovery
(%)
Puriﬁcation level (mg
sGAG/mg protein)
None SF 100 2−6.6
Boiled SF Supernatant 63 79
Blue Sepharose Flow through 67 28
Blue Sepharose & Mono-Q 3M elute 75 95
Blue Sepharose & Q-Sepharose 2M elute 68 925
Density centrifugation D1 86 5770
A1 92 732
Figure 1. Human synovial ﬂuid aggrecan fragments were puriﬁed by
(1) Blue Sepharose and Q-Sepharose; (2) Blue Sepharose and Mono-Q;
(3) Blue Sepharose; (4) D1 fraction; (5) Boiling SF, and analyzed by anti-
ARGS Western blot.
Results: The sGAG/total protein ratio was used as a measure of pu-
riﬁcation level of sGAG containing aggrecan fragments. The highest
puriﬁcation level was in the D1 fraction (Table 1). Blue Sepharose
or Q-Sepharose methods resulted in low puriﬁcation levels (30−40 mg
sGAG/mg protein), while a combination resulted in 20−30 times higher
puriﬁcation. A1 fraction showed similar puriﬁcation level, while puriﬁcation
with Blue Sepharose combined with Mono-Q, or boiling the SF resulted
in modest puriﬁcation levels (80–100mg sGAG/mg protein). Using the
chromatography and CsCl density centrifugation methods the sGAG
recoveries from SF samples were high, and highest yields were obtained
in D1 and A1 samples.
The Western blot immuno pattern of 2M and 3M eluates of anion
chromatography, exempliﬁed by the ARGS immuno pattern (Fig. 1), was
